TDOC - Top 4 Health Care Stocks That Are Preparing To Pump This Month | Benzinga
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
Inhibrx Biosciences, Inc. (NASDAQ:INBX)
- On May 24, Inhibrx stockholders approved sale of INBRX-101 to Sanofi. The company's stock fell around 50% over the past five days and has a 52-week low of $12.95.
- RSI Value: 15.08
- INBX Price Action: Shares of Inhibrx Biosciences fell 4.5% to close at $17.21 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest INBX news.